RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 
Regulatory Focus™ > News Articles > Quality & Compliance: Regulatory Forces Shaping Biopharmaceutical QA/QC in 2010

Quality & Compliance: Regulatory Forces Shaping Biopharmaceutical QA/QC in 2010

Posted 01 June 2010

Over the last 10 years, I have presented my impressions of the impact of changing regulatory forces on biopharmaceutical quality assurance/quality control (QA/QC) in the 21st century.1,2 Today, changing regulatory forces at both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) continue to shape biopharmaceutical QA/QC in the following three ways:

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe